🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 single-arm, open-label clinical trial determining efficac...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2020-02-19
Trial ID
NCT04231851
This phase II trial studies the side effects and how well Vyxeos works in t...
Status
Recruiting
Location
UC Davis Comprehensive Cancer Center
Start Date
2021-01-29
Trial ID
NCT04049539
Treatments Being Tested
Treatment with intensive chemotherapy in AML results in approximately 70% s...
Status
Recruiting
Location
St. Anna Kinderspital
Start Date
2020-11-06
Trial ID
NCT07156435
Treatments Being Tested
This phase II trial studies the effect of CPX-351 followed by donor stem ce...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2021-08-09
Trial ID
NCT04526288
This phase II trial studies the effect of adding pomalidomide to usual chem...
Status
Active Not Recruiting
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-08-24
Trial ID
NCT04802161
This phase I trial studies the best dose and side effects of liposomal cyta...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2021-05-21
Trial ID
NCT04915612
Treatments Being Tested
Use of magrolimab in combination with standard intensive chemotherapy ("7+3...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03-31
Trial ID
NCT05829434
Treatments Being Tested
This research is being done to assess the therapeutic activity of a promisi...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2021-05-20
Trial ID
NCT04801797
Treatments Being Tested
This phase II trial studies how well liposome-encapsulated daunorubicin-cyt...
Status
Active Not Recruiting
Location
University of Nebraska Medical Center
Start Date
2021-07-29
Trial ID
NCT04269213
Treatments Being Tested
This study is a Phase IV Expanded Access Protocol (EAP) of CPX-351 in patie...
Status
Approved For Marketing
Location
UCLA Ronald Reagan Medical Center
Start Date
TBD
Trial ID
NCT02533115
Treatments Being Tested